Skip to content
Frederik Stevenaert is an accomplished scientist with over 20 years of experience in biotech and pharmaceutical industry. Frederik's career trajectory saw him taking on various roles with increasing responsibilities in Research and Development. As a trained immunologist, at Johnson and Johnson he worked in the fields of chronic viral infections, immune-oncology and autoimmunity. With a strong interest in innovative therapeutic modalities, Frederik has led teams developing Treg therapies at Dualyx, targeted protein degradation therapeutics at Aelin Therapeutics and new vaccine modalities at Astrivax Therapeutics. Frederik holds a Master’s Degree in Biotechnology and a PhD in Biomedical Sciences from Ghent University.